Lexiscan
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Sickle Cell Disease
Conditions
Sickle Cell Disease
Trial Timeline
Apr 1, 2010 → Mar 1, 2013
NCT ID
NCT01085201About Lexiscan
Lexiscan is a phase 1 stage product being developed by Astellas Pharma for Sickle Cell Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT01085201. Target conditions include Sickle Cell Disease.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03103061 | Phase 2 | Completed |
| NCT01085201 | Phase 1 | Completed |
Competing Products
20 competing products in Sickle Cell Disease